Skip to main navigation Skip to search Skip to main content

Pharmacokinetic properties and bioequivalence of gefitinib 250 mg in healthy korean male subjects

Research output: Contribution to journalJournal articlepeer-review

Original languageKorean
JournalTranslational and Clinical Pharmacology
StatePublished - 2021.09.16

Cite this